Mariana Fitarelli-Kiehl

发表

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H inTP53

P. Ashton-Prolla, U. Matte, R. Schlatter, 2016, Genetics and molecular biology.

Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies.

Nikhil Wagle, Chen Song, Viktor A Adalsteinsson, 2017, Clinical chemistry.

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

J. C. Love, N. Lennon, T. Golub, 2020, Clinical Cancer Research.

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers

P. Ashton-Prolla, M. Graudenz, M. Achatz, 2015, Familial Cancer.

Enhanced detection of microsatellite instability using pre-PCR elimination of wild-type DNA homo-polymers in tissue and liquid biopsies

I. Ladas, H. Mamon, G. Makrigiorgos, 2018, Nucleic acids research.

A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil

P. Hainaut, P. Ashton-Prolla, M. Graudenz, 2013, Virchows Archiv.

Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

C. Paweletz, I. Ladas, S. Parangi, 2018, Clinical chemistry.

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers

P. Ashton-Prolla, M. Graudenz, M. Achatz, 2015, Familial Cancer.

Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease

I. Ladas, G. Makrigiorgos, Mariana Fitarelli-Kiehl, 2016, Nucleic acids research.

Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors.

D. Uchoa, M. Graudenz, C. Hartmann, 2014, Pathology, research and practice.